Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Transient Pharma AB
AB
Active
Org 5592007875
Medicon Village Scheeletorget 1, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Transient Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
MH
Maria Helene Lilian Hartman
Chief Executive Officer
Chief Executive Officer
2020
BU
Bertil Ulf Moritz Raue
Audit
Audit
2020
LJ
Lars Joakim Leifland
Auditor Substitute
Auditor Substitute
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
AC
Annette Carina Mattsson
Board of Directors
Board of Directors
2025
BT
Bo Ture David Benell
Chairman
Chairman
2020
JM
Johan Mikael Jensen
Board of Directors
Board of Directors
2020
AS
Artur Schmidtchen
Board of Directors
Board of Directors
2020
Former (1)
LM
Lena Mårtensson Wernrud
Board of Directors
Board of Directors
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Transient Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network